Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the "docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019): Editorial Comment

Samir S. Taneja

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Re: Survival with Newly Diagnosed Metastatic Prostate Cancer in the "docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019): Editorial Comment'. Together they form a unique fingerprint.